Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome.
Ernest V PedapatiLauren M SchmittLauren E EthridgeMakoto MiyakoshiJohn A SweeneyRui LiuElizabeth SmithRebecca C ShafferKelli C DominickDonald L GilbertSteve W WuPaul S HornDevin K BinderMartine A LamyMegan AxfordCraig A EricksonPublished in: Communications biology (2022)
Fragile X Syndrome (FXS) is a monogenetic form of intellectual disability and autism in which well-established knockout (KO) animal models point to neuronal hyperexcitability and abnormal gamma-frequency physiology as a basis for key disorder features. Translating these findings into patients may identify tractable treatment targets. Using source modeling of resting-state electroencephalography data, we report findings in FXS, including 1) increases in localized gamma activity, 2) pervasive changes of theta/alpha activity, indicative of disrupted thalamocortical modulation coupled with elevated gamma power, 3) stepwise moderation of low and high-frequency abnormalities based on female sex, and 4) relationship of this physiology to intellectual disability and neuropsychiatric symptoms. Our observations extend findings in Fmr1 -/- KO mice to patients with FXS and raise a key role for disrupted thalamocortical modulation in local hyperexcitability. This systems-level mechanism has received limited preclinical attention but has implications for understanding fundamental disease mechanisms.
Keyphrases
- intellectual disability
- resting state
- high frequency
- functional connectivity
- autism spectrum disorder
- transcranial magnetic stimulation
- end stage renal disease
- working memory
- chronic kidney disease
- ejection fraction
- newly diagnosed
- case report
- peritoneal dialysis
- stem cells
- metabolic syndrome
- bone marrow
- big data
- machine learning
- cell therapy
- sleep quality
- replacement therapy
- physical activity
- artificial intelligence